Tirzepatide
Written By Dr. Lipika Khurana
Reviewed By Dr. Mekhala ChandraLast updated 01 Apr 2026 | 11:51 AM (UTC)
Tirzepatide Uses
Tirzepatide is used in the treatment of type 2 diabetes mellitus and obesity.
How Tirzepatide works
Tirzepatide mimics and enhances the activity of two naturally occurring hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which regulate blood sugar, appetite, and energy balance. It increases insulin secretion in response to high blood sugar while reducing glucagon, a hormone that raises blood sugar levels, leading to improved glucose control.
Additionally, Tirzepatide slows the rate at which food leaves the stomach, prolonging the feeling of fullness and reducing the urge to eat more. It also acts on brain receptors to suppress appetite and promote satiety. This dual-receptor action makes Tirzepatide more effective in lowering blood sugar and supporting weight loss than single-hormone therapies.
Additionally, Tirzepatide slows the rate at which food leaves the stomach, prolonging the feeling of fullness and reducing the urge to eat more. It also acts on brain receptors to suppress appetite and promote satiety. This dual-receptor action makes Tirzepatide more effective in lowering blood sugar and supporting weight loss than single-hormone therapies.
Common side effects of Tirzepatide
Abdominal pain, Indigestion, Nausea, Vomiting, Diarrhea, Constipation
Want to Know More
Read Our Editorial PolicyMedicine brands for Tirzepatide
Expert advice for Tirzepatide
- Administer Tirzepatide on the same day each week to maintain consistent blood sugar control. Set a reminder to help you stay on track.
- To prevent skin irritation or lumps, administer the medication to different areas of the abdomen, thigh, or upper arm.
- Monitor blood sugar levels regularly to prevent hypoglycemia.
- Eat small, frequent, balanced meals, and avoid greasy, high-fat foods to reduce nausea.
- Drink plenty of water to counteract potential dehydration from nausea, vomiting, or diarrhea.
- Be watchful for symptoms such as severe stomach pain, signs of pancreatitis, or allergic reactions, and consult a doctor immediately if they occur.
- Tirzepatide may reduce the effectiveness of oral hormonal contraceptives. Switch to a non-oral contraceptive method or use an additional barrier method (e.g., condoms) for 4 weeks after starting this medicine and for 4 weeks after each dose escalation.
- Let doctors know you are taking Tirzepatide before surgeries, as it may delay stomach emptying and increase aspiration risk.
- While Tirzepatide can aid in weight management, results take time, and maintaining a healthy lifestyle enhances its effectiveness.
Frequently asked questions for Tirzepatide
Tirzepatide is a prescription medication that contains tirzepatide as the active ingredient. It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Additionally, it supports weight management by reducing hunger and promoting weight loss when combined with healthy lifestyle changes, such as a balanced diet and regular exercise.
No, Tirzepatide is not insulin. It helps regulate blood sugar by increasing the release of natural insulin, lowering glucose production, and slowing digestion.
Tirzepatide is administered as a once-weekly injection under the skin of the abdomen, thigh, or upper arm. Inject it on the same day each week, regardless of meals. Rotate the injection site each time to avoid skin irritation. Always use a new needle for each administration and ensure the liquid is clear before use.
Tirzepatide helps with weight loss by reducing hunger, increasing feelings of fullness, and improving insulin sensitivity. This leads to reduced calorie intake and gradual weight loss over time.
Yes, Tirzepatide can cause hypoglycemia, especially when taken with insulin or other diabetes medications. Symptoms include dizziness, sweating, shakiness, and confusion. If these occur, consume a fast-acting source of sugar such as fruit juice, candy, or honey. Continue monitoring your blood sugar levels and consult your doctor if treatment adjustments are needed.
Tirzepatide should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC). It is also not recommended for those with multiple endocrine neoplasia syndrome type 2 (MEN 2) due to the risk of thyroid tumors. Individuals who have experienced serious allergic reactions to tirzepatide should avoid it. Those with a history of pancreatitis, severe gastrointestinal problems, or gastroparesis should use it with caution, as it may worsen these conditions. Patients with severe kidney or liver impairment should use it cautiously and only under medical supervision.
Tirzepatide is not recommended during pregnancy due to limited human safety data. Animal studies suggest potential fetal harm, although human effects remain unclear. Consult your doctor if you are pregnant or planning a pregnancy.
Tirzepatide is not necessarily a lifelong treatment for everyone. The duration depends on individual health status, treatment response, and lifestyle modifications. Some patients may adjust therapy over time based on medical evaluation. Always consult your doctor before discontinuing treatment.
Stopping Tirzepatide may increase blood sugar levels and cause the return of type 2 diabetes symptoms such as thirst, frequent urination, and fatigue. Weight regain may also occur gradually. Consult your doctor before making any changes to your treatment plan.
No. Tirzepatide may come in a single-use device or vial and should be used as instructed. Do not store or reuse any remaining medication, as this may lead to contamination, incorrect dosing, or reduced effectiveness. Consult your doctor if you have concerns about dosing.
Gently tap the syringe to move air bubbles to the top. Slowly push the plunger upward until it reaches the required dose marking to expel the air. If a small air bubble remains and does not move, it is unlikely to affect safety, quality, or effectiveness.
Store Tirzepatide in the refrigerator at 2°C to 8°C. It may be kept at room temperature (up to 30°C) for up to 21 days. Do not return it to the refrigerator once it has been stored at room temperature. Discard it if not used within 21 days after removal from refrigeration. Do not freeze. Keep it in its original carton to protect it from light.
Yes, Tirzepatide commonly causes gastrointestinal side effects such as nausea, vomiting, diarrhea, or constipation, particularly during treatment initiation. These occur because the medicine slows gastric emptying. If symptoms become severe or persistent, inform your doctor to discuss possible dose adjustment.
No. Tirzepatide is indicated for type 2 diabetes and weight management and is not a substitute for insulin in patients with type 1 diabetes. It requires some endogenous insulin production to be effective. Your doctor will confirm your diabetes type before prescribing it.
Yes, Tirzepatide slows gastric emptying, which may reduce the absorption and effectiveness of oral contraceptive pills. This effect is most significant when starting treatment or increasing the dose. Your doctor may recommend using an additional barrier method of contraception for at least 4 weeks after initiation or dose escalation.
Rapid weight loss associated with Tirzepatide may sometimes lead to a hollow facial appearance or loose skin due to loss of subcutaneous fat. This is not a direct side effect of the medication but a consequence of weight reduction. Your doctor may discuss nutritional strategies and skin health measures to help manage these changes.